Cognoptix CEO Dr. Susanne Wilke to Present at the 13th Annual BIOTECH SHOWCASE™ DIGITAL Event
Share this article Share this article MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ -- Cognoptix, a privately-held, diagnostics company with a breakthrough technology for the early detection of Alzheimers disease (AD), announces that the company will present at the 13 th Annual Biotech Showcase™ Digital Event, January 11-15, 2021. Dr. Susanne Wilke, Cognoptix President and CEO, will present an overview of the Cognoptix Sapphire II technology in a talk titled "Sapphire II: A Breakthrough Te...
Justine Lavoye Susanne Wilke Marketing Communications Alzheimer Association A Breakthrough Technology Cognoptix Inc
Source: prnewswire.com